Amarin Corporation plc (AMRN)
NASDAQ: AMRN · IEX Real-Time Price · USD
0.875
+0.015 (1.72%)
At close: Apr 26, 2024, 4:00 PM
0.897
+0.022 (2.55%)
After-hours: Apr 26, 2024, 6:46 PM EDT

Amarin Corporation Revenue

In the year 2023, Amarin Corporation had annual revenue of $306.91M, a decrease of -16.87%. Revenue in the quarter ending December 31, 2023 was $74.71M, a -17.21% decrease year-over-year.

Revenue (ttm)
$306.91M
Revenue Growth
-16.87%
P/S Ratio
1.17
Revenue / Employee
$1,116,040
Employees
275
Market Cap
357.68M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023306.91M-62.28M-16.87%
Dec 31, 2022369.19M-213.99M-36.69%
Dec 31, 2021583.19M-30.87M-5.03%
Dec 31, 2020614.06M184.31M42.89%
Dec 31, 2019429.76M200.54M87.49%
Dec 31, 2018229.21M48.11M26.56%
Dec 31, 2017181.10M51.02M39.22%
Dec 31, 2016130.08M48.33M59.11%
Dec 31, 201581.76M27.55M50.84%
Dec 31, 201454.20M27.85M105.69%
Dec 31, 201326.35M--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Health Catalyst 295.94M
Revance Therapeutics 234.04M
Zynex 184.32M
Heron Therapeutics 127.04M
ADC Therapeutics 69.56M
Aquestive Therapeutics 50.58M
Mersana Therapeutics 36.86M
Precigen 6.23M
Revenue Rankings